Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy

NCT05672979 is registered in ClinicalTrials.gov with Yeungnam University College of Medicine as lead sponsor.

NCT NCT05672979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy
Lead sponsor
Yeungnam University College of Medicine
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2023
Completion date
December 31, 2024
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, pachychoroid neovasculopathy